When should repeat anaplasmosis laboratory testing be performed for a patient with a positive IgG and negative IgM?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Repeat Anaplasmosis Testing for Positive IgG/Negative IgM

For a patient with positive IgG and negative IgM anaplasmosis serology, repeat testing should be performed 2-4 weeks after the initial sample to demonstrate a fourfold rise in IgG titer, which is required for serologic confirmation of acute infection 1.

Understanding the Serologic Pattern

Your patient's positive IgG with negative IgM pattern has three possible interpretations:

  • Past infection with persistent antibodies (most likely) - IgG antibodies against A. phagocytophilum can persist for over 4 years after acute illness 1
  • Very early acute infection - approximately 45% of PCR-confirmed cases are seronegative at initial presentation 2
  • Late acute/convalescent infection - IgM may be absent or have waned while IgG is rising

The Critical Timing Issue

Serologic testing during the first week of illness has limited sensitivity - only 55% of PCR and culture-confirmed anaplasmosis cases are seropositive at presentation 2. However, all evaluable seronegative patients in this study developed antibodies during convalescence when retested 6-45 days later 2.

The 2016 CDC guidelines emphasize that IFA assays are insensitive during the first week of rickettsial infection, which is when most patients seek care 1. Sensitivity increases substantially 2-3 weeks after illness onset.

Recommended Testing Algorithm

If acute anaplasmosis is clinically suspected:

  1. Collect the acute sample immediately (which you already have)
  2. Obtain a convalescent sample 2-4 weeks later 1
  3. Test both samples in tandem using IFA for IgG antibodies
  4. Confirmation requires a fourfold or greater rise in IgG titer between acute and convalescent samples 1

Important caveat: A single elevated IgG titer (even ≥64) is never sufficient to confirm acute infection 1. In endemic regions, 5-10% of the general population has detectable IgG antibodies to A. phagocytophilum from prior exposure 1.

Clinical Decision Points

Do not wait for serology to treat if clinical suspicion is high. The guidelines are clear that treatment decisions should be based on clinical presentation and epidemiologic factors, not serology alone 1.

Consider PCR testing on whole blood if the patient is still symptomatic and within the first week of illness - this is the most sensitive direct diagnostic test during acute infection 2, 3. PCR positivity can occur even when serology is negative 3.

Common Pitfalls to Avoid

  • Don't interpret the positive IgG as confirming acute infection - it likely represents past exposure
  • Don't rely on IgM testing - IgM antibodies have lower specificity and can produce false positives in patients without recent infection 1
  • Don't delay treatment waiting for convalescent serology if clinical suspicion is high based on symptoms (fever, headache) and laboratory abnormalities (thrombocytopenia, leukopenia, transaminitis) 4

The presence of ≥4 routine laboratory abnormalities (leukopenia, thrombocytopenia, bandemia, hyponatremia, transaminitis) has a positive likelihood ratio of 12.96 for HGA 4, which should guide empiric treatment decisions while awaiting confirmatory testing.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.